Our Team
CNS considers itself well versed in the needs of both Australian and non-Australian healthcare companies having worked with many local, US and European clients since our inception in 1998. Indeed, several CNS team members have worked for US and European-based Biotech, Pharma, Device and CRO companies, often based in those countries, adding to CNS' understanding of our client’s expectations and the challenges they face commercially and in satisfying the regulators.
As a small boutique CRO, CNS is proud of its ability to offer our clients CNS project teams who average over 10 years clinical experience per person, and through provision of dynamic and stimulating challenges in our early phase niche, we are able to maintain great stability internally with less than 10% staff turnover over the last five years.
Prof Tony (AJ) Webber – CEO & Executive Director
Tony brings over 40 years of academic and commercial experience to CNS which he established in 1998. Following his position as Dean of Health & Science at Queensland University of Technology from 1980 to 1996, where he was instrumental in the spinout of intellectual property into Australia's emerging Biotechnology industry, Tony has continued to promote Australia's unique advantages international, being the first Australian to exhibit at many of the US/Europe's summer conferences, both as CEO for CNS and more recently as President of Queensland Clinical Trial Network (QCTN).
"CNS was established as a specialist CRO with the aim of assisting small to medium size pharmaceutical and biotechnology companies manage product development for their potential therapeutics emerging from pre-clinical studies, through “proof of concept” and “first in man”.
Russell Neal - Chief Operating Officer
Russell has been advising clients in clinical trial management for over 17 years. Initially as a CRA/PM, he moved with Quintiles to Sydney before moving to Singapore in 1999. In 2003, Russell returned to Australia following three years as Regional Training Manager Asia Pacific and is currently responsible for the day to day running of CNS' business.
"The unique blend of backgrounds and experience that we have at CNS gives us a great insight into our clients needs and expectations. We find it an advantage being a small delivery-focussed company enabling us to be as flexible as our clients require us to be. Coupled with our extensive experience working with Australasia's motivated research clinicians and specialised units, CNS is uniquely positioned to bring these aspects together as solutions for our clients assisting them in fast tracking the early stages of their development programs."
Gabrielle McKee – Director Clinical Research
With over 14 years managing clinical teams and projects at international CROs and local biotechnology companies, Gabby offers both our Clients and CNS' own team her unique insight into clinical management. As Director of Clinical Research Gabby actively works across all project teams lending her experience to the team and being an additional resource for our clients.
"Helping to bring new technology and treatments into the international market place from Australia has always been a personal dream; that we are doing this everyday with a fantastic team of very qualified, experienced clinical research professionals is a delight. CNS' unique business model has grown around the needs of our clients and the needs of our team of expert consultants, a balance that we strive to maintain and foster in every aspect of our work."
